Evidence map›Paper›PMID 33985463›Full record

ArticleBMC ophthalmology2021

Compound heterozygous missense mutations in a Chinese mucopolysaccharidosis type VI patient: a case report.

Ming-Fang He, Ji Yang, Meng-Jie Dong, Yin-Ting Wang, Hai Liu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Mucopolysaccharidosis Type VI, an Updated Overview of the Disease.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ming-Fang He *Department of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
Ji Yang *Department of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
Meng-Jie DongDepartment of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
Yin-Ting WangDepartment of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
Hai LiuDepartment of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China. 2111516127@e.gzhu.edu.cn.ORCID http://orcid.org/0000-0002-5001-6903
Yunnan University · CNKunming Medical University · CN

Funding

The funding of eye disease clinical medical center of Yunnan province YXZX-2019058Yunnan provincial Major science and technology Foundation 2018ZF009
6 · The paper itself

Abstract

backgroundMucopolysaccharidosis type VI (MPS VI) is a rare autosomal recessive inherited disease caused by mutations in the arylsulfatase B (ARSB) gene. MPS VI is a multisystemic disease resulting from a deficiency in arylsulfatase B causing an accumulation of glycosaminoglycans in the tissues and organs of the body. In this report, we present the case of a 16-year-old Chinese male who presented with vision loss caused by corneal opacity. MPS VI was confirmed by genetic diagnosis. CASE PRESENTATION: A 16-year-old Chinese male presented with a one-year history of binocular vision loss. The best-corrected visual acuity was 0.25 in the right eye and 0.5 in the left eye. Although slit-lamp examination revealed corneal opacification in both eyes, the ocular examinations of his parents were normal. At the same time, the patient presented with kyphotic deformity, short stature, joint and skeletal malformation, thick lips, long fingers, and coarse facial features. Genetic assessments revealed that ARSB was the causative gene. Compound heterozygous missense mutations were found in the ARSB gene, namely c.1325G > A (p. Thr442Met) (M1) and c.1197G > C (p. Phe399Leu) (M2). Genetic diagnosis confirmed that the patient had MPS VI.

conclusionsThis paper reports a case of MPS VI confirmed by genetic diagnosis. MPS VI is a multisystem metabolic disease, with corneal opacity as a concomitant ocular symptom. As it is difficult for ophthalmologists to definitively diagnose MPS VI, genetic testing is useful for disease confirmation.

Indexed as

Mucopolysaccharidosis VIN-Acetylgalactosamine-4-SulfataseAdolescentChinaHumansMaleMutationMutation, MissenseN-Acetylgalactosamine-4-SulfataseARSB gene missense mutationCorneal opacityMucopolysaccharidosis type VI

Identifiers

PMID33985463
PMCPMC8120710
OpenAlexW3163375870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.